Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers.

Pissa, Maria; Lapins, Jan; Sköldmark, Christina; Helgadottir, Hildur

Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers.

Pissa, Maria; Lapins, Jan; Sköldmark, Christina; Helgadottir, Hildur.

Affiliation

Pissa M; Department of Dermatology and Venereology, Ryhov County Hospital, Jönköping, Sweden.
Lapins J; Department of Medicine, Unit of Dermatology, Karolinska Institutet, Stockholm, Sweden.
Sköldmark C; Department of Dermatology, Skin Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
Helgadottir H; Department of Dermatology and Venereology, Ryhov County Hospital, Jönköping, Sweden.

J Eur Acad Dermatol Venereol ; 37(2): 284-292, 2023 Feb.

Article in En | MEDLINE | ID: mdl-36156317

Subject(s)

Melanoma; Skin Neoplasms; Humans; Adult; Skin Neoplasms/pathology; Melanoma/pathology; Cyclin-Dependent Kinase Inhibitor p16/genetics; Germ-Line Mutation; Mutation; Genetic Predisposition to Disease; Melanoma, Cutaneous Malignant

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Humans Language: En Journal: J Eur Acad Dermatol Venereol Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google